ATE254173T1 - P75 tnf-rezeptor-promotoren - Google Patents

P75 tnf-rezeptor-promotoren

Info

Publication number
ATE254173T1
ATE254173T1 AT95919786T AT95919786T ATE254173T1 AT E254173 T1 ATE254173 T1 AT E254173T1 AT 95919786 T AT95919786 T AT 95919786T AT 95919786 T AT95919786 T AT 95919786T AT E254173 T1 ATE254173 T1 AT E254173T1
Authority
AT
Austria
Prior art keywords
promotors
tnf receptor
sequence
upstream
preparation
Prior art date
Application number
AT95919786T
Other languages
English (en)
Inventor
David Wallach
Peter Kuhnert
Gotz Ehrhardt
Oliver Kemper
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE254173T1 publication Critical patent/ATE254173T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT95919786T 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren ATE254173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter
PCT/US1995/005853 WO1995031206A1 (en) 1994-05-11 1995-05-11 P75 tnf receptor promoters

Publications (1)

Publication Number Publication Date
ATE254173T1 true ATE254173T1 (de) 2003-11-15

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919786T ATE254173T1 (de) 1994-05-11 1995-05-11 P75 tnf-rezeptor-promotoren

Country Status (13)

Country Link
EP (1) EP0759759B1 (de)
JP (1) JP3663211B2 (de)
AT (1) ATE254173T1 (de)
AU (1) AU699280B2 (de)
CA (1) CA2189984C (de)
CY (1) CY2524B1 (de)
DE (1) DE69532115T2 (de)
DK (1) DK0759759T3 (de)
ES (1) ES2206505T3 (de)
IL (1) IL109633A (de)
PT (1) PT759759E (de)
WO (1) WO1995031206A1 (de)
ZA (1) ZA953841B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
LT2773354T (lt) 2011-11-01 2019-08-12 Resverlogix Corp. Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos
US10125168B2 (en) 2012-09-20 2018-11-13 Toagosei Co. Ltd. Synthetic peptide for adjusting balance between presence of type 1 TNF receptor and type 2 TNF receptor and use thereof

Also Published As

Publication number Publication date
AU2546895A (en) 1995-12-05
CA2189984C (en) 2008-03-25
IL109633A0 (en) 1994-08-26
CY2524B1 (en) 2006-02-08
DK0759759T3 (da) 2004-02-02
IL109633A (en) 2005-05-17
DE69532115T2 (de) 2004-08-26
CA2189984A1 (en) 1995-11-23
EP0759759A4 (de) 1997-11-26
JP3663211B2 (ja) 2005-06-22
WO1995031206A1 (en) 1995-11-23
JPH10500304A (ja) 1998-01-13
PT759759E (pt) 2004-01-30
DE69532115D1 (de) 2003-12-18
AU699280B2 (en) 1998-11-26
EP0759759A1 (de) 1997-03-05
ZA953841B (en) 1996-01-17
ES2206505T3 (es) 2004-05-16
EP0759759B1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
DK0662005T3 (da) Mikropartikelpræparater af biologisk nedbrydelige copolymerer
TR199501635A1 (tr) Solunum yolu ile alinan terapötik preparatlar.
EP0675225A3 (de) Weiches einlagiges Seidenpapier mit sehr niedriger Oberseite/Unterseite-Asymetrie.
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
ATE254173T1 (de) P75 tnf-rezeptor-promotoren
MY106522A (en) Arylaminocarbonyl compounds.
ITMI913465A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
ZA966489B (en) New protein human MP52 Arg.
ZA969645B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides.
ZA200202823B (en) Self-cleaving RNA sequences and their use for the control of protein synthesis.
ITMI942671A0 (it) Catalizzatori per la (co) polinerizzazione dell'etilene
GB2325466A (en) Nucleotide sequence from goat liver
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
ITTO920958A1 (it) Doccia per uso terapeutico.
ITRM950130V0 (it) Bidet con rubinetto disposto frontalmente all'utilizzazione.
McNamee Voiceprints
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
温儒敏 The Modernity of Wang Guowei's Literary Criticism
FR2717073B1 (fr) Bac à shampoing pour malades allongés, notamment pour grabataires.
FR2703251B3 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .
王永昌 On the Notion of Practice
GB9006500D0 (en) Therapeutic agents,and intermediates for the synthesis thereof
IT1284498B1 (it) Ago adatto per la terapia sclerosante delle varici.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0759759

Country of ref document: EP

REN Ceased due to non-payment of the annual fee